Results 11 to 20 of about 209,758 (346)

The impact of combined oral contraceptives on ocular tissues: a review of ocular effects [PDF]

International Journal of Ophthalmology, 2017
The aim of this manuscript is to review the action and adverse effects of combined oral contraceptives (COCs) on ocular tissues. The percentage of unwanted pregnancies and the subsequent abortions make contraception crucial worldwide.
Marilita M. Moschos, Eirini Nitoda
doaj   +2 more sources

Altered pharmacokinetics of combined oral contraceptives in obesity - multistudy assessment. [PDF]

Contraception, 2019
OBJECTIVE The objective was to evaluate the pharmacokinetics (PKs) of levonorgestrel (LNG)-containing combined oral contraceptives (COCs) in obese women.
Luo D, Westhoff CL, Edelman AB, Natavio M, Stanczyk FZ, Jusko WJ.   +5 more
europepmc   +2 more sources

Use of Combined Oral Contraceptives in Perimenopausal Women. [PDF]

Chonnam Med J, 2018
While perimenopausal women have low fecundity, they are still capable of becoming pregnant and the majority of pregnancies occurring during perimenopause are unintended pregnancies.
Cho MK.
europepmc   +2 more sources

The effect of lavender on mood disorders associated with the use of combined oral contraceptives (COCs): a triple-blinded randomized controlled trial [PDF]

BMC Complementary Medicine and Therapies
Background The use of contraceptive methods is influenced by their effectiveness, availability, and minimal side effects. OCPs are one of the most effective and widely used methods of pregnancy prevention worldwide.
Mina Naghdi, Azizeh Farshbaf-Khalili, Jila Nahaee, Parvin Hakimi, Mahnaz Shahnazi   +4 more
doaj   +2 more sources

Oral contraceptives and tissue factor expression. Comments on “Do combined oral contraceptives induce formation of tissue factor?” [PDF]

Research and Practice in Thrombosis and Haemostasis
Bjarne Østerud
doaj   +2 more sources

Investigating cardiovascular risk in premenopausal women on oral contraceptives: Systematic review with meta-analysis

Frontiers in Cardiovascular Medicine, 2023
BackgroundThe use of oral contraceptives (OCs) is associated with an increased risk of cardiovascular events such as arterial and venous thrombosis (VTE).
Oyesanmi A. Fabunmi, Oyesanmi A. Fabunmi, Phiwayinkosi V. Dludla, Bongani B. Nkambule   +3 more
doaj   +1 more source

Use of combined oral contraceptives and risk of venous thromboembolism in young women: a nested case–control analysis using German claims data

BJOG: an International Journal of Obstetrics and Gynaecology, 2022
To compare the risk of venous thromboembolism (VTE) among young women for nine combined oral contraceptives (COCs), including progestogens with an as yet unclear risk of VTE such as chlormadinone and nomegestrol, using COCs containing levonorgestrel with
T. Schink, Christina Princk, M. Braitmaier, U. Haug   +3 more
semanticscholar   +1 more source

Efficacy of combined oral contraceptives for depressive symptoms and overall symptomatology in premenstrual syndrome: pairwise and network meta-analysis of randomized trials.

American Journal of Obstetrics and Gynecology, 2021
OBJECTIVE Combined oral contraceptives are often considered a treatment option for women with premenstrual syndrome (PMS) or premenstrual dysphoric disorder (PMDD) also seeking contraception, but evidence for this treatment is scarce.
Anouk E. de Wit, Y. D. de Vries, M. D. de Boer, C. Scheper, Ante Fokkema, Catharina A. H. Janssen, E. Giltay, R. Schoevers   +7 more
semanticscholar   +1 more source

Reproductive behavior of medical students: realities of contraceptive choice [PDF]

Гинекология, 2018
Representations of the society about the use of hormonal drugs for protection from unwanted pregnancy have the features of a deeply rooted behavioral and social stigmatization.
T A Oboskalova, O V Prohorova
doaj   +1 more source

There is no association between combined oral hormonal contraceptives and depression: a Swedish register‐based cohort study

BJOG: an International Journal of Obstetrics and Gynaecology, 2021
To investigate whether users of hormonal contraceptives (HCs) are at increased risk of depression compared with non‐users.
C. Lundin, A. Wikman, E. Lampa, M. Bixo, K. Gemzell‐Danielsson, Per Wikman, R. Ljung, I. Sundström Poromaa   +7 more
semanticscholar   +1 more source